Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Archives of General Psychiatry|September 1, 1982
The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonistS Korsgaard, D E Casey, J Gerlach, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1992
A longitudinal study of correlations among tardive dyskinesia, drug-induced parkinsonism, and psychosisT E Hansen, R M Weigel, W L Brown, et al.Neuroscience|September 7, 2010
Antipsychotic drugs dose-dependently suppress the spontaneous hyperactivity of the chakragati mouseG S Dawe, R Nagarajah, R Albert, et al.Advances in Biochemical Psychopharmacology|January 1, 1985
Five-year follow-up study of tardive dyskinesiaG Gardos, J O Cole, A Perenyi, et al.International Journal of Obesity (2005)|March 30, 2005
Antipsychotic drug-induced weight gain: development of an animal modelM B Cope, T R Nagy, J R Fernández, et al.International Journal of Clinical Practice|September 9, 2014
Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapyD E Casey, K K Laubmeier, J M Eudicone, et al.Psychopharmacology|January 1, 1996
Movements in never-medicated schizophrenics: a preliminary studyD S Fenn, D Moussaoui, W F Hoffman, et al.The American Journal of Psychiatry|June 1, 1994
Ten-year outcome of tardive dyskinesiaG Gardos, D E Casey, J O Cole, et al.Psychiatry Research|April 20, 2001
Estimating the consequences of anti-psychotic induced weight gain on health and mortality rateK R Fontaine, M Heo, E P Harrigan, et al.The Journal of Clinical Psychiatry|March 1, 1993
Dose response of prophylactic antipsychoticsJ M Davis, J M Kane, S R Marder, et al.Pageof 12